
Kantipur Pharmaceuticals Lab Limited is opening its Initial Public Offering (IPO) for project-affected local residents from Mangsir 10.
The company is issuing 800,000 ordinary shares worth Rs. 8 crore at a face value of Rs. 100 per share. The shares represent 10% of the company’s issued capital of Rs. 80 crore and are reserved for residents of Ward No. 7 of Panchkhal Municipality, Kavrepalanchok.
Eligible local residents can apply for a minimum of 10 shares and a maximum of 10,000 shares.
The IPO will close early on Mangsir 24 and, at the latest, on Poush 13.
Muktinath Capital Limited has been appointed as the issue and sales manager. Local residents can submit applications through the Banepa and Panchkhal branches of Muktinath Bikas Bank and Sindhu Bikas Bank. Applicants will have to pay Rs. 2 for the application form.
Kantipur Pharmaceuticals Lab Limited (KPLL) has launched its IPO in the Manufacturing sector, seeking to raise Rs. 80,000,000. The offering consists of 800,000 units priced at Rs. 100.00 per unit, with Muktinath Capital Limited serving as the issue manager.
The subscription period, which is open to Local, is scheduled from November 26, 2026 to December 10, 2026, with a minimum application requirement of 10 units.





Note: This result link is hosted on the official website of the issue manager and provides the same allotment data published by CDSC.
For faster access during high traffic periods, it is recommended to use the CDSC IPO result portal or the issue manager’s official website.